Bixellou: "If that's true, those are lousy odds."

Bixellou: "If that's true, those are lousy odds."

______________________________________

I disagree. I think these odds (10-15%) are realistic for P2 with 75 patients and intermediate 50 patients in P2/3. Realistic, considering the degree of systemic corruption. If they don't give us EUA in July it's not the end of the world. They will have to approve P3 trial for M/M and it will enroll fast news about our STELLAR results in P2 will spread in medical community as a wildfire. Also with 10 or so P2/3 trial centers I guess we already have well over 100 patients enrolled and the enrollment will speed up greatly with our July news. In the meantime, the authorization for 100M new shares will allow our NASH P2 to enroll asap and with only 90 patients get STELLAR results by early 2021 at the latest. Ditto with our mono, TNBC, cancer basket, Alzheimer, etc.
_____________________________________

ofm20: "Someone more cynical they me, wonders will never cease. What changes the proposition is the public will know leronlimab saves lives. Any politician or FDA hack that wants to fight that is taking on millions of people.

Read More: https://investorshangout.com/post/view?id=580...z6QZi6AblE
__________________________________________

I'd like to think of myself as a realist . This realism tells me that "the public" if you mean by it millions of people cannot learn about the saving powers of our drug because they can learn about it only from mass media which is a part of the systemic corruption aka mega corporate capitalism and all its men. Unless this system wants them to learn. For now our allies is not "the public" but medical profession and, especially, world renowned clinical centers of science like Montefiore, as well as healthcare providers like Novant whose bottom line depends on introducing effective drugs like leronlimab. Our third ally which to my knowledge we have not connected as yet is a network of organizations and individuals who are interested in resisting BP's power over our health and lives. We also must begin forming a lobbying group even if of modest size for beginners. Apart from saving and healing people, Leronlimab may yet become a rallying point for democratization of our society.

Finally, I believe the company can rely on the core group of its longs to withstand any malicious attacks by shorts and hostile takeovers. Many of us have already recovered their CYDY investment, knowledgeable of its science and determined to see its success. In other words, I see absolutely no grounds for disillusionment, let alone panic, if we don't get approved in July. GLTA

Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.